Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised, placebo-controlled trial in healthy humans of modified cellulose or psyllium evaluating the role of gelation in altering colonic gas production during inulin co-administration.

Food & function·2026
Same author

Role of fermentation-resistant and non-fermentable fibers in gastrointestinal health: mechanisms, benefits, and challenges.

Critical reviews in food science and nutrition·2026
Same author

Global guidelines on diverticular disease of the colon: the Fiesole Consensus report.

Gut·2025
Same author

Length of the Adult Human Colon in Health and Constipation Measured Using Magnetic Resonance Imaging.

Neurogastroenterology and motility·2025
Same author

Insulin-like peptide 5 is released in response to bile acid in the rectum and is associated with diarrhoea severity in patients with bile acid diarrhoea.

Gut·2025
Same author

Mode of Action of Psyllium in Reducing Gas Production from Inulin and its Interaction with Colonic Microbiota: A 24-hour, Randomized, Placebo-Controlled Trial in Healthy Human Volunteers.

The Journal of nutrition·2024
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Potential biomarkers.

Robin C Spiller1

  • 1NIHR Biomedical Research Unit, Nottingham Digestive Diseases Centre, E Floor West Block, University Hospital, Nottingham, NG7 2UH, UK. robin.spiller@nottingham.ac.uk

Gastroenterology Clinics of North America
|February 22, 2011
PubMed
Summary
This summary is machine-generated.

Currently, only radio-isotope gut transit tests are reproducible and available biomarkers for Irritable Bowel Syndrome (IBS). Future research aims to find more convenient blood and stool biomarkers for IBS diagnosis.

More Related Videos

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
10:05

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

Related Experiment Videos

Last Updated: Jun 4, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
10:05

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

Area of Science:

  • Gastroenterology
  • Biomarker Research

Background:

  • Biomarkers are objectively measurable indicators of bodily functions.
  • Identifying reliable biomarkers for Irritable Bowel Syndrome (IBS) is crucial for diagnosis and management.

Purpose of the Study:

  • To review the current status of biomarkers for IBS.
  • To assess the reproducibility and availability of potential IBS biomarkers.

Main Methods:

  • Review of existing literature on IBS biomarkers.
  • Evaluation of gut transit studies using radio-isotope markers.
  • Consideration of barostat studies and their limitations.
  • Discussion of potential future biomarkers such as blood and stool tests.

Main Results:

  • Currently, only radio-isotope measurement of gut transit meets criteria for reproducibility and availability as an IBS biomarker.
  • Barostat studies show promise in expert centers but lack standardization for widespread use.
  • Existing methods like radio-isotope tests are costly and not widely available.

Conclusions:

  • There is an ongoing need for convenient and accessible biomarkers for IBS.
  • Future research should focus on developing reliable blood and stool tests for IBS.